Historical Valuation
CARSGEN-B (02171) is now in the Fair zone, suggesting that its current forward PS ratio of 7.53 is considered Fairly compared with the five-year average of -12.61. The fair price of CARSGEN-B (02171) is between 15.84 to 47.77 according to relative valuation methord.
Relative Value
Fair Zone
15.84-47.77
Current Price：16.39
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
CARSGEN-B (02171) has a current Price-to-Book (P/B) ratio of 8.51. Compared to its 3-year average P/B ratio of 4.48 , the current P/B ratio is approximately 89.82% higher. Relative to its 5-year average P/B ratio of 4.20, the current P/B ratio is about 102.52% higher. CARSGEN-B (02171) has a Forward Free Cash Flow (FCF) yield of approximately -4.82%. Compared to its 3-year average FCF yield of -11.80%, the current FCF yield is approximately -59.19% lower. Relative to its 5-year average FCF yield of -10.61% , the current FCF yield is about -54.60% lower.
Performance Decomposition
AI Analysis
1Y
3Y
5Y
Market capitalization of 02171 increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of 02171 in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is 02171 currently overvalued or undervalued?
CARSGEN-B (02171) is now in the Fair zone, suggesting that its current forward PS ratio of 7.53 is considered Fairly compared with the five-year average of -12.61. The fair price of CARSGEN-B (02171) is between 15.84 to 47.77 according to relative valuation methord.
What is CARSGEN-B (02171) fair value?
02171's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of CARSGEN-B (02171) is between 15.84 to 47.77 according to relative valuation methord.
How does 02171's valuation metrics compare to the industry average?
The average P/S ratio for 02171's competitors is , providing a benchmark for relative valuation. CARSGEN-B Corp (02171) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for CARSGEN-B (02171) as of Jan 16 2026?
As of Jan 16 2026, CARSGEN-B (02171) has a P/B ratio of 8.51. This indicates that the market values 02171 at 8.51 times its book value.
What is the current FCF Yield for CARSGEN-B (02171) as of Jan 16 2026?
As of Jan 16 2026, CARSGEN-B (02171) has a FCF Yield of -4.82%. This means that for every dollar of CARSGEN-B’s market capitalization, the company generates -4.82 cents in free cash flow.
What is the current Forward P/E ratio for CARSGEN-B (02171) as of Jan 16 2026?
As of Jan 16 2026, CARSGEN-B (02171) has a Forward P/E ratio of -41.98. This means the market is willing to pay $-41.98 for every dollar of CARSGEN-B’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for CARSGEN-B (02171) as of Jan 16 2026?
As of Jan 16 2026, CARSGEN-B (02171) has a Forward P/S ratio of 7.53. This means the market is valuing 02171 at $7.53 for every dollar of expected revenue over the next 12 months.